Search Results
Baricitinib versus placebo or adalimumab on patient-reported outcomes in rheumatoid arthritis
Baricitinib had improved patient-reported outcomes in the treatment of rheumatoid arthritis
Outcomes in an RCT study of baricinitab in patients with rheumatoid arthritis
Baricitinib and its combination with Methotrexate is efficient for Rheumatoid arthritis patients
Infections in baricitinib clinical trials for patients with active rheumatoid arthritis
Discussing Rheumatology: Baricitinib Safety and Treatment Interruptions
Discussing Rheumatology: Baricitinib and Itacitinib
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs
JAK Inhibitors in Rheumatoid Arthritis
The RheumNow Week in Review – FDA Showdown for Baricitinib (4.27.18)
CTAF: Evidence Presentation, Rheumatoid Arthritis
Advances in Rheumatoid Arthritis
